THE U.S. Food and Drug Administration said on Tuesday that it is investigating reports of two deaths due to acute liver failure in non-ambul...

The supplemental application is based on data from a phase 3 study of children aged 2-12 years with mild-to-moderate AD, randomly assigned t...

PALM BEACH GARDENS, Fla., June 24, 2025 /PRNewswire/ -- A second child has died after receiving Elevidys, an experimental gene therapy for D...

Saudi Gazette report RIYADH — The World Health Organization (WHO) has officially designated the Saudi Food and Drug Authority (SFDA) as its...

VADUZ, Liechtenstein, June 24, 2025 /PRNewswire/ -- Implantica AG (publ.), a MedTech company at the forefront of introducing advanced techno...

The antibody drug conjugate, previously approved for HR+ HER2- breast cancer, is also now indicated for certain previously treated EGFR-muta...

The recent approval of lenacapavir, marketed as Yeztugo, by the FDA marks a pivotal advancement in HIV prevention strategies. As the first a...

The recent approval of lenacapavir, marketed as Yeztugo, by the FDA marks a pivotal advancement in HIV prevention strategies. This injectabl...

New Delhi:  While Gilead Sciences’ HIV prevention drug lenacapavir got approved by the US Food and Drug Administration (FDA), its made-in-In...

By LINDSAY WHITEHURSTWASHINGTON (AP) — The Supreme Court sided with e-cigarette companies on Friday in a ruling making it easier to sue ove...

Treatment with dupilumab improved disease remission and significantly reduced itching compared with placebo. Medscape Medical News

Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has suspended imports from an international medical device and suppli...

Twice a year dosing shows potential for improved PrEP uptake and adherence. Medscape Medical News

In clinical trials, researchers found Yeztugo to be highly effective as a twice-yearly form of pre-exposure prophylaxis.

The Food and Drug Administration has approved the world’s only twice-a-year shot to prevent HIV